These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21641346)

  • 1. Potential impact of optimal implementation of evidence-based heart failure therapies on mortality.
    Fonarow GC; Yancy CW; Hernandez AF; Peterson ED; Spertus JA; Heidenreich PA
    Am Heart J; 2011 Jun; 161(6):1024-30.e3. PubMed ID: 21641346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How well are chronic heart failure patients being managed?
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
    From AM; Borlaug BA
    Cardiovasc Ther; 2011 Aug; 29(4):e6-21. PubMed ID: 20370792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure with normal left ventricular ejection fraction: what is the evidence?
    Kindermann M; Reil JC; Pieske B; van Veldhuisen DJ; Böhm M
    Trends Cardiovasc Med; 2008 Nov; 18(8):280-92. PubMed ID: 19345315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
    Fonarow GC; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Inge PJ; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circulation; 2010 Aug; 122(6):585-96. PubMed ID: 20660805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.
    Fonarow GC; Gheorghiade M; Abraham WT
    Am J Cardiol; 2004 Nov; 94(9):1155-60. PubMed ID: 15518610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).
    Albert NM; Fonarow GC; Yancy CW; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride M; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am Heart J; 2010 Feb; 159(2):238-44. PubMed ID: 20152222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
    Fonarow GC; Abraham WT; Albert NM; Gattis Stough W; Gheorghiade M; Greenberg BH; O'Connor CM; Pieper K; Sun JL; Yancy CW; Young JB;
    Arch Intern Med; 2007 Jul; 167(14):1493-502. PubMed ID: 17646603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study reveals wide variations in guideline-based heart failure care.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jul; 15(13):10, 12. PubMed ID: 15272489
    [No Abstract]   [Full Text] [Related]  

  • 13. Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians.
    Remme WJ; McMurray JJ; Hobbs FD; Cohen-Solal A; Lopez-Sendon J; Boccanelli A; Zannad F; Rauch B; Keukelaar K; Macarie C; Ruzyllo W; Cline C;
    Eur Heart J; 2008 Jul; 29(14):1739-52. PubMed ID: 18506054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF).
    Forman DE; Cannon CP; Hernandez AF; Liang L; Yancy C; Fonarow GC;
    Am Heart J; 2009 Jun; 157(6):1010-7. PubMed ID: 19464411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial).
    O'Connor CM; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; McBride ML; Inge PJ; Mehra MR; Reynolds D; Walsh MN; Yancy CW; Fonarow GC
    Am J Cardiol; 2011 Jan; 107(2):250-8. PubMed ID: 21211602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme.
    de Groote P; Isnard R; Clerson P; Jondeau G; Galinier M; Assyag P; Demil N; Ducardonnet A; Thebaut JF; Komajda M
    Eur J Heart Fail; 2009 Jan; 11(1):85-91. PubMed ID: 19147461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF).
    Albert NM; Fonarow GC; Yancy CW; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride M; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am J Cardiol; 2010 Jun; 105(12):1773-9. PubMed ID: 20538129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the management of heart failure: differences in guideline perspectives.
    Jessup M; Brozena SC
    Cardiol Clin; 2007 Nov; 25(4):497-506; v. PubMed ID: 18063155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry.
    Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; Mehra M; O'Connor CM; Reynolds D; Walsh MN
    Am Heart J; 2007 Jul; 154(1):12-38. PubMed ID: 17584548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.